跳至主要内容
临床试验/NCT07786012
NCT07786012尚未招募4 期

The BUMP Trial: Intrathecal Buprenorphine Versus Morphine for Postcesarean Analgesia-A Randomized Noninferiority Trial

Icahn School of Medicine at Mount Sinai1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2026年9月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
180
试验地点
1
主要终点
Morphine equivalents administered within 24 hours after spinal administration

研究概览

简要总结

In this study the researchers are randomizing pregnant patients coming for elective cesarean delivery to receive either intrathecal buprenorphine or morphine for their analgesia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Assignments done via opaque envelopes. Separate team will break envelopes and draw up study medication.

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •- Presenting for singleton elective cesarean delivery at term gestation.

排除标准

  • •allergy to buprenorphine or morphine
  • •will not have neuraxial anesthesia
  • •chronic pain conditions
  • •opiate based medications

研究组 & 干预措施

Buprenorphine

Experimental

Patients receive 60 mcg buprenorphine as a part of their spinal medications.

干预措施: buprenorphine (Drug)

Morphine

Active Comparator

Patients receive 125 mcg morphine as a part of their spinal medications

干预措施: morphine (Drug)

结局指标

主要结局

Morphine equivalents administered within 24 hours after spinal administration

时间窗: 24 hours

The total sum of opiates will be converted into morphine equivalents and compared between the groups for the first 24 hours after the spinal is administered.

次要结局

  • Morphine Equivalents at 48 Hours(48 hours)
  • Morphine Equivalents at 72 Hours(72 hours)
  • Obstetric Quality of Recovery-10 (ObsQoR-10) Score(24 hours, 48 hours, and 72 hours post spinal administration)
  • Pruritus Scores PACU(during PACU stay, about 6 hours)
  • Pruritus Scores POD1-3(at 24 hours intervals for 72 hours)
  • Floor Pain Scores over 24 hours(through 24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniel Katz

Professor

Icahn School of Medicine at Mount Sinai

研究点 (1)

Loading locations...

相似试验